• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma, Inc. - Common Stock (NQ:SILO)

    0.4603 +0.0109 (+2.43%)
    Streaming Delayed Price Updated: 3:45 PM EDT, Apr 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 396,021
    Open 0.4491
    Bid (Size) 0.4501 (700)
    Ask (Size) 0.4699 (500)
    Prev. Close 0.4494
    Today's Range 0.4467 - 0.4715
    52wk Range 0.2210 - 1.130
    Shares Outstanding 98,671,970
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Highlights Federal Momentum Advancing Psychedelic Therapeutics Development
    Via Investor Brand Network
    News headline image
    Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
    From Silo Pharma, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +37.2%
    +37.2%
    1 Month
    +34.4%
    +34.4%
    3 Month
    +26.1%
    +26.1%
    6 Month
    -14.5%
    -14.5%
    1 Year
    -43.2%
    -43.2%

    More News

    Read More
    Top movers in Thursday's session ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Into AI With Qwikagents Asset Acquisition
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
    From Silo Pharma, Inc.
    Via GlobeNewswire
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    Which stocks are most active on Tuesday? ↗
    Via Chartmill
    On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    Which stocks are moving on Tuesday? ↗
    Via Chartmill
    Gapping stocks in Tuesday's session ↗
    Via Chartmill
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances IP Portfolio With EPO Notice of Intent to Grant Patent
    Via Investor Brand Network
    Topics Intellectual Property
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    Via Chartmill
    News headline image
    Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
    From Silo Pharma, Inc.
    Via GlobeNewswire
    Curious about the stocks that are showing activity after the closing bell on Friday? ↗
    Via Chartmill
    MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Authorizes $1 Million Share Repurchase Program
    Via Investor Brand Network
    Which stocks are moving before the opening bell on Tuesday? ↗
    Via Chartmill
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Silo Pharma Announces Share Buyback Program
    From Silo Pharma, Inc.
    Via GlobeNewswire
    BioMedNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Receives Japan Patent Allowance for SPC-15 PTSD Candidate10
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
    From Silo Pharma, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Silo Pharma, Inc. - Common Stock publicly traded?
    Yes, Silo Pharma, Inc. - Common Stock is publicly traded.
    What exchange does Silo Pharma, Inc. - Common Stock trade on?
    Silo Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Silo Pharma, Inc. - Common Stock?
    The ticker symbol for Silo Pharma, Inc. - Common Stock is SILO on the Nasdaq Stock Market
    What is the current price of Silo Pharma, Inc. - Common Stock?
    The current price of Silo Pharma, Inc. - Common Stock is 0.4603
    When was Silo Pharma, Inc. - Common Stock last traded?
    The last trade of Silo Pharma, Inc. - Common Stock was at 04/30/26 03:45 PM ET
    What is the market capitalization of Silo Pharma, Inc. - Common Stock?
    The market capitalization of Silo Pharma, Inc. - Common Stock is 45.42M
    How many shares of Silo Pharma, Inc. - Common Stock are outstanding?
    Silo Pharma, Inc. - Common Stock has 45M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.